WAVE Life Sciences (NASDAQ:WVE) just reported results for the first quarter of 2024.
- WAVE Life Sciences reported earnings per share of -24 cents. This was below the analyst estimate for EPS of -21 cents.
- The company reported revenue of $12.54 million.
- This was 45.37% worse than the analyst estimate for revenue of $22.95 million.